-
Product Insights
E Nash PV3 Solar PV Park
E Nash PV3 Solar PV Park is a solar PV project located in North Carolina, United States. The project is owned and being developed by Ecoplexus Inc. The project is expected to come online in 2025. Empower your strategies with our E Nash PV3 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efruxifermin in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efruxifermin in Liver Cirrhosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efruxifermin in Liver Cirrhosis Drug Details: Efruxifermin (AKR-001) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efruxifermin in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efruxifermin in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efruxifermin in Metabolic Dysfunction-Associated Steatotic Liver Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Efruxifermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Efruxifermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Efruxifermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: Efruxifermin...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Insulin Human in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Insulin Human in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Insulin Human in Type 1 Diabetes (Juvenile Diabetes)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CS-0159 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CS-0159 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CS-0159 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: CS-0159 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Omesdafexor in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Omesdafexor in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Omesdafexor in Type 2 Diabetes Drug Details: Omesdafexor (MET-409) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LY-3885125 in Dyslipidemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LY-3885125 in Dyslipidemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LY-3885125 in Dyslipidemia Drug Details: LY-3885125 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Sucunamostat in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sucunamostat in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sucunamostat in Type 2 Diabetes Drug Details: Sucunamostat (SCO-792) is under...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PB-718 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PB-718 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PB-718 in Type 2 Diabetes Drug Details: PB-718 is under development...